Clinical trials on HIV neutralising antibodies

Clinical trials examining broadly neutralising antibodies could hold critical information to protect high-risk communities from HIV. The trials are currently underway at CAPRISA, the Centre for the Aids Programme of Research in South Africa, in Durban. According to the World Health Organisation, in 2021 there were over 38 million people living with HIV globally. And women in sub-Saharan Africa continue to bear the brunt of the disease. For more news, visit sabcnews.com and also #SABCNews on all Social Media platforms.